Articles, guides, and regulatory updates from our community.
How peptides like BPC-157, larazotide, and KPV are being studied for gastrointestinal conditions — from inflammatory bowel disease to intestinal barrier repair.
By Peptide Association Editorial Team
The GLP-1 revolution has rewritten the rules of obesity treatment. How incretin-based peptide therapies achieve what diet and exercise alone cannot — and what comes next.
By Peptide Association Editorial Team
A comprehensive safety guide covering side effects, drug interactions, quality concerns, and red flags — essential reading for anyone considering or currently using peptide therapy.
By Peptide Association Editorial Team
The regulatory landscape for compounded peptides has shifted dramatically. Here's what clinicians must understand about FDA enforcement, 503A/503B rules, and the bulk drug substance list.
By Peptide Association Editorial Team
An honest assessment of BPC-157 research — separating the extensive animal data from the limited human evidence, and what providers should tell patients asking about this popular peptide.
By Peptide Association Editorial Team
How to evaluate compounding pharmacies, understand USP standards, interpret certificates of analysis, and ensure your patients receive safe, accurately dosed peptide products.
By Peptide Association Editorial Team
How the copper-binding tripeptide GHK-Cu influences wound healing, collagen synthesis, and gene expression — and what the evidence says about its anti-aging potential.
By Peptide Association Editorial Team
How mitochondrial-derived peptides like MOTS-c and humanin intersect with NAD+ biology to influence aging, metabolic health, and cellular resilience.
By Peptide Association Editorial Team
A head-to-head comparison of the two leading GLP-1 receptor agonists — mechanisms of action, clinical trial data, side effects, and practical considerations for providers and patients.
By Peptide Association Editorial Team
How CJC-1295, ipamorelin, tesamorelin, and other GH secretagogues work — the physiology, clinical evidence, and practical protocols for growth hormone optimization.
By Peptide Association Editorial Team
A deep dive into thymosin alpha-1 — the endogenous thymic peptide with decades of clinical research supporting its role in immune modulation, viral infections, and as an immunotherapy adjunct.
By Peptide Association Editorial Team
Everything you need to know about peptide therapy — from the science behind short-chain amino acids to clinical applications, delivery methods, and how to find a qualified provider.
By Peptide Association Editorial Team
How bremelanotide (PT-141) works through melanocortin receptors to address hypoactive sexual desire disorder — mechanism, clinical data, and practical prescribing considerations.
By Peptide Association Editorial Team
How peptides like DSIP, epitalon, and GH secretagogues can support sleep architecture, recovery, and circadian health — the evidence and practical protocols.
By Peptide Association Editorial Team